Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Research & Development (2022 - 2025)

Historic Research & Development for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to $809777.0.

  • 60 Degrees Pharmaceuticals' Research & Development fell 1385.93% to $809777.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 5346.87%. This contributed to the annual value of $5.0 million for FY2024, which is 62083.58% up from last year.
  • Per 60 Degrees Pharmaceuticals' latest filing, its Research & Development stood at $809777.0 for Q3 2025, which was down 1385.93% from $249884.0 recorded in Q2 2025.
  • In the past 5 years, 60 Degrees Pharmaceuticals' Research & Development ranged from a high of $3.1 million in Q2 2024 and a low of $27655.0 during Q3 2022
  • For the 4-year period, 60 Degrees Pharmaceuticals' Research & Development averaged around $543434.6, with its median value being $256793.5 (2023).
  • Per our database at Business Quant, 60 Degrees Pharmaceuticals' Research & Development skyrocketed by 141826.93% in 2024 and then plummeted by 9192.71% in 2025.
  • Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' Research & Development stood at $203457.0 in 2022, then crashed by 50.75% to $100201.0 in 2023, then skyrocketed by 512.72% to $613955.0 in 2024, then soared by 31.9% to $809777.0 in 2025.
  • Its last three reported values are $809777.0 in Q3 2025, $249884.0 for Q2 2025, and $407622.0 during Q1 2025.